| P2093 | author name string | Xu Liu | |
| | Jiang Chen | |
| | Hong-Yu Li | |
| | Xiao-Zhong Guo | |
| | Di Wang | |
| | Jia-Jun Zhao | |
| | Li-Nan Ren | |
| P2860 | cites work | Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin | Q22008776 |
| | Pancreatic cancer | Q29616288 |
| | Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design | Q33595455 |
| | Muc4/MUC4 functions and regulation in cancer | Q33674729 |
| | Prognostic value of mucin 4 expression in colorectal adenocarcinomas | Q34023248 |
| | Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases | Q34060189 |
| | Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. | Q34500864 |
| | Survivin and pancreatic cancer | Q35000802 |
| | Current diagnosis and treatment of pancreatic cancer in China | Q36169302 |
| | Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients | Q37064709 |
| | Dendritic cell-based cancer immunotherapies | Q37500014 |
| | Significance of mucin expression in pancreatobiliary neoplasms | Q37604931 |
| | Cellular vaccine approaches | Q37778690 |
| | Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer. | Q37832190 |
| | Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro | Q39467521 |
| | High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy | Q39493057 |
| | Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA. | Q40013674 |
| | Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma | Q40365927 |
| | Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells. | Q40646153 |
| | Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells | Q40701084 |
| | Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate | Q43252637 |
| | A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform | Q44401579 |
| | Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer. | Q51739914 |
| | Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA | Q56967613 |
| | MUC4 gene polymorphism and expression in women with implantation failure | Q79810459 |
| | Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination | Q80966511 |
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| | pancreatic cancer | Q212961 |
| P304 | page(s) | 4585-4590 | |
| P577 | publication date | 2013-08-06 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA. | |
| P478 | volume | 31 | |